Abstract
In dermatology, patients with nodosum leprosum and discoid lupus erythematosus are benefited by clofazi‐mine therapy. Its use in other autoimmune diseases has to be considered. Patients with lupus pernio may respond to this regime, but further prolonged trials will have to be undertaken.

This publication has 2 references indexed in Scilit: